La Innovative Medicines Initiative anticipa i contenuti dei futuri bandi IMI 2: supporto alla ricerca e all’innovazione

La Innovative Medicines Initiative anticipa i contenuti dei futuri bandi IMI 2 che saranno lanciati in autunno 2015:

  • Joint influenza vaccine effectiveness surveillance
  • Development of quantitative system toxicology (QST) approaches to improve the understanding of the safety of new medicines
  • Establishing impact of RSV (respiratory syncytial virus) infection, resultant disease and public health approach to reducing the consequences

Topics under the Big Data for Better Outcomes programme:

  • Coordination and Support Action (CSA) for the Big Data for Better Outcomes programme
  • Real world outcomes across the AD (Alzheimer’s disease) spectrum (ROADS) to better care
  • Development of an outcomes-focused platform to empower policy makers and clinicians to optimize care for patients with haematologic malignancies

Le anticipazioni sopra riportate sono indicative e potrebbero essere soggette a modifiche. Le informazioni definitive sui futuri bandi IMI saranno comunicate in seguito all’approvazione da parte dell’IMI Governing Board.

maggiori informazioni: http://first.aster.it/_aster_/viewNews?ID=34001

Leave a Reply